Treatment study concerning the influence of self-regulation on undesirable eating behaviour (binging) among people with boulimia nervosa or binge eating disorder.

Treatment study concerning the influence of self-regulation on undesirable eating behaviour (binging) among people with boulimia nervosa or binge eating disorder. - Study on the influence of self-regulation on undesirable eating behaviour

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON55658

Enrollment

105

Registered

2015-09-16

Start date

2016-03-09

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Boulimia nervosa and Binge eating disorder

Interventions

Participants are randomly divided into three groups. The first (experimental) group will be receiving a treatment with behavioral regulation-IIs focused directly on the binge itself. The second (exp

they only form goal intentions. In each group there are three individual weekly treatment sessions, during three weeks.

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Boulimia Nervosa or Binge Eating Disorder diagnosed according to the DSM-V criteria. - age: 18 years or older

Exclusion criteria

Exclusion criteria: - Anorexia Nervosa diagnosed according to the DSM-V criteria. - BMI

Design outcomes

Primary

Measure	Time frame
The ultimate goal is to reduce the number of binges. This is measured by (1) the foodintake diary, which specifically requests binge eating, (2) the Eating Disorder Examination Questionnaire (EDE-Q; Fairburn & Beglin, 1994) and (3) the Eating Disorder Inventory-II (EDI II ; Garner & Van Strien, 2002).	—

Secondary

Measure	Time frame
A secundary study parameter is negative affect. This will be measured by the Positive and Negative Affect Schedule (PANAS; Watson, Clark & Tellegen, 1988).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)